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ORIGINAL ARTICLE

Impact of the Coronavirus Disease
2019 (COVID-19) Pandemic on Imaging
Case Volumes
Jason J. Naidich, MD, MBA a,b,e , Artem Boltyenkov, PhD, MBA c,d, Jason J. Wang, PhD e,
Jesse Chusid, MD, MBAf,g, Danny Hughes, PhD h,i, Pina C. Sanelli, MD, MPH e, j,k
Abstract
Objective: The coronavirus disease 2019 (COVID-19) pandemic has had signiﬁcant economic impact on radiology with markedly
decreased imaging case volumes. The purpose of this study was to quantify the imaging volumes during the COVID-19 pandemic across
patient service locations and imaging modality types.
Methods: Imaging case volumes in a large health care system were retrospectively studied, analyzing weekly imaging volumes by patient
service locations (emergency department, inpatient, outpatient) and modality types (x-ray, mammography, CT, MRI, ultrasound,
interventional radiology, nuclear medicine) in years 2020 and 2019. The data set was split to compare pre-COVID-19 (weeks 1-9) and
post-COVID-19 (weeks 10-16) periods. Independent-samples t tests compared the mean weekly volumes in 2020 and 2019.
Results: Total imaging volume in 2020 (weeks 1-16) declined by 12.29% (from 522,645 to 458,438) compared with 2019. PostCOVID-19 (weeks 10-16) revealed a greater decrease (28.10%) in imaging volumes across all patient service locations (range
13.60%-56.59%) and modality types (range 14.22%-58.42%). Total mean weekly volume in 2020 post-COVID-19 (24,383 [95%
conﬁdence interval 19,478-29,288]) was statistically reduced (P ¼ .003) compared with 33,913 [95% conﬁdence interval 33,42934,396] in 2019 across all patient service locations and modality types. The greatest decline in 2020 was seen at week 16 speciﬁcally for
outpatient imaging (88%) affecting all modality types: mammography (94%), nuclear medicine (85%), MRI (74%), ultrasound (64%),
interventional (56%), CT (46%), and x-ray (22%).
Discussion: Because the duration of the COVID-19 pandemic remains uncertain, these results may assist in guiding short- and longterm practice decisions based on the magnitude of imaging volume decline across different patient service locations and speciﬁc imaging
modality types.
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INTRODUCTION
In a short time, the coronavirus disease 2019 (COVID-19)
pandemic has had a devastating global impact on the health of
the population with an overwhelming demand for health care
resources. As of May 3, 2020, a total of 3,502,956 cases have
been reported worldwide with 245,081 deaths [1]. With 210
countries battling the pandemic, the United States has quickly
become most severely affected with 1,160,996 cases and
67,448 deaths reported [1]. Within the United States, New
York State has become the epicenter of COVID-19, representing over one-fourth of the cases (319,213) and over onethird of the deaths (24,368) reported in the country [1].
Community spread of the virus in an environment without
pre-existing immunity continues to pose a serious health
risk to the population.
Although social isolation policies have been successful in
slowing the spread of COVID-19 [2], it has also led to a
signiﬁcant downturn of the US economy with stock
market declines [3] and continuous rise in unemployment
[4]. The economic impact has affected both small and
large companies struggling to survive in almost every
business sector, including health care. During this period,
health care institutions and providers have been instructed
to stop performing elective surgical procedures to slow the
spread of disease and conserve health care resources for
COVID-19 patients. Furthermore, ACR has endorsed
guidance from the Centers for Disease Control and Prevention to reschedule nonurgent outpatient visits [5].
As a consequence of public policy, ﬁnancial hardship, and
patient fear, many radiology departments have experienced a
rapid decline in imaging case volumes. This has important
implications on the short- and long-term economic stability of
radiology departments across all practice settings. However,
only anecdotal evidence currently exists without a clear understanding of the magnitude of reduced imaging case volumes across different patient service locations (emergency
department, inpatient, outpatient) and speciﬁc imaging modality types (x-ray, mammography, CT, MRI, ultrasound,
interventional radiology, nuclear medicine).
The purpose of this study was to evaluate the impact of
the COVID-19 pandemic on imaging case volumes using
real-world data from a large health care institution. We
analyzed the weekly imaging volumes during the COVID19 pandemic stratiﬁed by patient service locations and imaging modality types.

locations and imaging modality types. Our institution is the
largest health care system in New York State, consisting of
23 hospitals (academic, community, and specialty), 52 urgent care centers, and 17 imaging centers, serving a highly
diverse mix of racial, ethnic, and socioeconomic groups. The
imaging case volumes were provided as aggregate data for
each week (Sunday to Saturday) in 2019 and 2020 stratiﬁed
by patient service locations (emergency department, inpatient, outpatient) and imaging modality types (x-ray,
mammography, CT, MRI, ultrasound, interventional radiology, nuclear medicine). Our health care system had no
overall changes in the number of imaging scanners available
for x-ray, mammography, CT, MRI, ultrasound, interventional procedures, and nuclear medicine examinations between 2019 and 2020 that would have affected the expected
imaging case volumes during the COVID-19 pandemic.
The institutional review board approved a waiver to use the
retrospective aggregate data.

COVID-19 History in New York City
In New York City, the ﬁrst conﬁrmed patient tested positive
for COVID-19 on March 1, 2020 (week 10, day 1). The ﬁrst
conﬁrmed patient in our health care system tested positive on
March 8, 2020 (week 11, day 1). Due to the rapid growth in
COVID-19–positive cases, New York City quickly became
the epicenter of the pandemic in the United States.
To lower the risk of exposure and transmission to health
care providers, staff, and patients and to minimize contamination of equipment during the transportation and scanning
of COVID-19 patients, careful review of the need for imaging in all patients was performed. On March 27, 2020
(week 13, day 6), our Department of Radiology issued
guidelines for appropriate use of imaging in the emergency,
inpatient, and outpatient settings. All nonurgent imaging
was avoided in patients with conﬁrmed or suspected
COVID-19, if possible. The guidelines also recommended
avoiding imaging procedures, when possible, that required
health care providers to be in close contact with patients with
COVID-19, such as ultrasound and interventional procedures. In the inpatient setting, the guidelines emphasized
limiting imaging to those procedures that could not safely be
performed in an outpatient setting after discharge. In
particular, the judicious use of chest CT imaging in patients
with COVID-19 was suggested for hospitalized symptomatic
patients with speciﬁc clinical indications (ie, concern for
bacterial superinfection, intubation-related barotrauma, etc).

METHODS
A retrospective review of the imaging case volumes in a large
health care system was performed from January 1, 2019, to
April 18, 2020, to evaluate the impact of the COVID-19
pandemic on the imaging volumes by patient service
866

Statistical Analysis
The imaging case volumes were provided for each imaging
modality type (x-ray, mammography, CT, MRI, ultrasound,
interventional radiology, nuclear medicine) in aggregate sum
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Table 1. Imaging case volumes in 2020 and 2019 for the total (weeks 1-16) and pre-COVID-19 (weeks 1-9) and post-COVID19 (weeks 10-16) periods stratiﬁed by patient service locations and imaging modality types
2020 Year

2019 Year

Total (Weeks
1-16)

Pre-COVID-19
(Weeks 1-9)

Post-COVID-19
(Weeks 10-16)

Total volume

458,438

287,759

170,679

522,645

285,257 237,388

Patient location
Emergency
Inpatient
Outpatient

221,151
162,470
74,817

138,570
94,302
54,887

82,581
68,168
19,930

247,639
175,511
99,495

135,060 112,579
96,609 78,902
53,588 45,907

Modality type
X-ray
Mammography
Ultrasound
CT
MRI
Nuclear medicine
Interventional

241,965
11,232
55,918
115,315
18,858
5,747
9,403

141,303
8,557
38,992
75,485
13,321
4,050
6,051

100,662
2,675
16,926
39,830
5,537
1,697
3,352

259,804
14,320
69,561
134,494
24,399
7,912
12,155

142,460 117,344
7,887
6,433
37,701 31,860
73,284 61,210
13,065 11,334
4,274
3,638
6,586
5,569

Imaging Volumes

Total (Weeks Weeks Weeks 101-16)
1-9
16

COVID-19 ¼ coronavirus disease 2019.

data according to the patient service locations (emergency
department, inpatient, outpatient) for each week 1 to 16 in
both 2020 and 2019 calendar years. The data set was split
for analysis to compare the pre-COVID-19 period (weeks 19) and post-COVID-19 period (weeks 10-16). In the 2019
data, week 1 was adjusted to match 4 days of imaging
volume data in 2020 for adequate comparison by eliminating January 1, 2019, imaging volumes from the data
analysis.
The frequency data for each week were summed for the
total weeks 1 to 16 pre-COVID-19 and post-COVID-19
periods according to patient service locations and imaging
modality types. Descriptive frequency data were plotted
separately to demonstrate the trend in the weekly imaging
case volumes in 2020 from weeks 1 to 16 according to patient service locations and imaging modality types. The
percent difference in the 2020 imaging case volumes was
calculated by week for the total weeks 1 to 16 and preCOVID-19 and post-COVID-19 periods, compared with
the 2019 imaging volumes, stratiﬁed by patient service locations and imaging modality types. The difference in the
imaging volumes in the 2020 calendar year were compared
with the same weeks in 2019 to assess the degree of change
accounting for monthly or seasonal variation within the same
calendar year. The trend in the percentage of the 2020
weekly imaging case volumes, relative to 2019, was plotted
from weeks 1 to 16 according to the patient service locations.
The mean weekly imaging volumes were calculated for
each imaging modality type stratiﬁed by patient service locations for the total weeks 1 to 16 and pre-COVID-19 and
Journal of the American College of Radiology
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post-COVID-19 periods. Independent-samples t tests were
performed comparing the mean weekly imaging case volumes in years 2020 and 2019 for each imaging modality
type stratiﬁed by patient service locations for the total weeks
1 to 16 and pre-COVID-19 and post-COVID-19 periods.
Statistical signiﬁcance was considered for P values < .05. All
statistical analyses were performed using SAS v9.4 (SAS,
North Carolina).

RESULTS
The total imaging case volume performed at our institution
in year 2020 from weeks 1 to 16 was 458,438 examinations,
compared with 522,645 examinations in 2019 during the
same period (weeks 1-16). Table 1 displays the imaging case
volumes according to patient service locations and imaging
modality types for the total weeks 1 to 16 and preCOVID-19 (weeks 1-9) and post-COVID-19 (weeks 1016) periods in 2020 and 2019. Figure 1 demonstrates the
trend in the imaging case volumes in 2020 across weeks 1
to 16 stratiﬁed by patient service locations. Figure 2
reveals the trend in the imaging case volumes in 2020
across weeks 1 to 16 stratiﬁed by imaging modality types.
Imaging case volumes in 2020 began to decline in week
10 (when the ﬁrst conﬁrmed patient tested positive for
COVID-19 in New York City).
Table 2 reveals the percent difference in the imaging
case volumes between 2020 and 2019 for the total weeks
1 to 16 and pre-COVID-19 (weeks 1-9) and postCOVID-19 (weeks 10-16) periods, according to patient
service locations and imaging modality types. In weeks 1 to
867

Fig 1. The 2020 imaging case volume trend across weeks 1 to 16 stratiﬁed by patient service locations. The vertical red line at
week 10 indicates when the ﬁrst patient in New York City tested positive for coronavirus disease 2019. Calendar weeks are
presented on the x axis and number of imaging examinations on the y axis. ED ¼ emergency department.

16, the total imaging volume decreased by 12.29%
compared with the same period in 2019. However, when
separating the total weeks into the pre-COVID-19 and postCOVID-19 periods, the total imaging volume increased by
0.88% in the pre-COVID-19 (weeks 1-9) period and
decreased by 28.10% in the post-COVID-19 (weeks 10-16)
period in year 2020 compared with the same weeks in 2019.
In year 2020, the imaging case volumes declined in the postCOVID-19 period across all patient service locations (range
13.60%-56.59%) and imaging modality types (range
14.22%-58.42%). By week 16, the 2020 imaging case
volumes declined by 45.56%, 4.15%, and 87.55% for
emergency department, inpatient, and outpatient imaging,
respectively. We also observed a shift in imaging volume
with increased use of x-ray relative to cross-sectional imaging. When excluding x-ray, the decline in volume at week
16 was 54.96%, 37.80%, and 87.20% for emergency
department, inpatient, and outpatient imaging, respectively.
Figure 3 demonstrates the trend in the percentage of the
2020 imaging case volumes relative to 2019 across weeks
1 to 16 by patient service locations, with declines
observed after week 10 in the post-COVID-19 period. At
week 16, the 2020 imaging case volumes represented
54.44%, 95.85%, and 12.45% of the imaging volume in
2019 for the emergency department, inpatient, and outpatient settings, respectively.
Table 3 shows the comparison of the 2020 and 2019
mean weekly imaging case volumes in the post-COVID19 period (weeks 10-16) for the imaging modality types
stratiﬁed by patient service locations. In the pre-COVID-19
period, there was no statistical difference (P ¼ .905) in the
868

mean weekly imaging volumes in 2020 (31,973 [95%
conﬁdence interval 27,978-35,967]) compared with 2019
(31,695 [95% conﬁdence interval 28,194-35,195]). However, statistically signiﬁcant differences (P ¼ .003) were seen
in the mean weekly imaging case volumes in the
post-COVID-19 period with total volume decreased to
24,383 (95% conﬁdence interval 19,478-29,288) in 2020
compared with 33,913 (95% conﬁdence interval 33,42934,396) in 2019 and across all patient service locations and
imaging modality types.

DISCUSSION
The COVID-19 pandemic has given rise to unprecedented
and unpredictable circumstances for radiology practices.
Anecdotal experience suggests that radiology practices
should anticipate 50% to 70% decreases in imaging volume
that will last a minimum of 3 to 4 months, depending on
the location of practice and the severity of the COVID-19
pandemic in each region [6]. To prepare a short-term and
long-term response to the COVID-19 crisis, the need for
real-world data is essential to understand the magnitude of
reduced imaging case volumes across the different patient
service locations and speciﬁc imaging modality types.
The results from this study have revealed an overall 28%
decline in the total imaging volume over a 7-week period
during the COVID-19 pandemic (weeks 10-16) compared
with 2019, including all patient service locations and imaging
modality types. Even though this decline in imaging volumes
seems less than the anecdotal evidence suggesting a 50% to
70% decline [6], the trend data have shown a transition
Journal of the American College of Radiology
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Fig 2. The 2020 imaging case volume trend across weeks 1 to 16 stratiﬁed by imaging modality types. The vertical red line at
week 10 indicates when the ﬁrst patient in New York City tested positive for coronavirus disease 2019. (A) Imaging volume
data for x-ray, CT, and ultrasound (US) examinations. (B) Imaging volume data for interventional radiology (IR), mammography
(Mammo), MRI, and nuclear medicine (Nuc Med) examinations. Calendar weeks are presented on the x axis and number of
imaging examinations on the y axis.

period with a steep decline rate observed from weeks 10 to
13. Thus, we have observed the greatest percent difference
in the 2020 imaging case volumes after the transition
period at week 16 (40%). Furthermore, this study has
demonstrated that the imaging volume deterioration has
varied by location, with the greatest declines observed at
week 16 in the outpatient setting (maximum year-over-year
decline of 88%) followed by the emergency department
(46%) and inpatient (4%) settings. Imaging volume deterioration also varied by modality type, with the greatest declines observed at week 16 in mammography (94%),
followed in descending order by nuclear medicine (85%),
Journal of the American College of Radiology
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MRI (74%), ultrasound (64%), interventional radiology
(56%), CT (46%), and x-ray (22%).
To our knowledge, there is no published study
describing the magnitude of the decline in imaging case
volumes during the COVID-19 pandemic stratiﬁed by both
patient service locations and imaging modality types.
Importantly, this study used the prior year 2019 weekly data
for comparison to account for potential bias from monthly
and seasonal variation. In addition, our health care system
had no overall changes in the number of imaging scanners
available for x-ray, mammography, CT, MRI, ultrasound,
interventional procedures, and nuclear medicine
869

Table 2. Percent change in the 2020 imaging volumes,
compared with 2019, for the total (weeks 1-16) and preCOVID-19 (weeks 1-9) and post-COVID-19 (weeks 10-16)
periods, and week 16 stratiﬁed by patient service locations
and imaging modality types
Percent Change in 2020 Imaging
Volumes Compared With 2019
Weeks Weeks Weeks
1-16
1-9
10-16

Week
16

Total volume

12.29 þ0.88 28.10

40.14

Patient location
Emergency
Inpatient
Outpatient

10.70 þ2.60 26.65
7.43 2.39 13.60
24.80 þ2.42 56.59

45.56
4.15
87.55

Modality type
X-ray
Mammography
Ultrasound
CT
MRI
Nuclear medicine
Interventional

6.87
21.56
19.61
14.26
22.71
27.36
22.64

22.16
93.58
63.69
46.46
73.57
85.03
55.57

Imaging Volumes

0.81
þ8.49
þ3.42
þ3.00
þ1.96
5.24
8.12

14.22
58.42
46.87
34.93
51.15
53.35
39.81

COVID-19 ¼ coronavirus disease 2019.

examinations between 2019 and 2020 that would have
affected the expected imaging case volumes during the
COVID-19 pandemic. Given that our health care institution is comprised of different practice settings, the stratiﬁed

data may be applicable to other radiology practices that are
comprised mainly of either outpatient or inpatient settings.
There are signiﬁcant economic implications on radiology groups and health care systems mainly due to the
resultant combined lost revenue and stafﬁng needs [6]
during the pandemic. Several policy changes have been
enacted to limit the transmission of COVID-19. Federal
and state governments have mandated nonessential
business closures and “stay-at-home” orders. In addition,
health care policies have recommended the pause of
elective and routine medical services, particularly surgical
procedures and imaging examinations. However,
individual behavior and actions have also contributed to
the decline in imaging case volumes. The general public is
hesitant to visit any health care facility for fear of being
exposed to the coronavirus (SARS-CoV-2), in particular
the emergency department [7]. This has raised concerns
regarding the potential adverse health outcomes in patients
delaying care for emergent conditions, such as acute
stroke, myocardial infarction, appendicitis, and so on.
Even though health care institutions can apply for
interim funding relief from a variety of government remedies including the CARES Act [8], Treasury’s Exchange
Stabilization Fund [9], and Medicare [10], more radiology
practices will be challenged to survive in a constrained
economic environment as the pandemic ensues. Thus,
many practices will need to make short-term changes to
survive this period and permanent changes to the radiology
practice model may be necessary in the long term [6]. In

Fig 3. The trend in the percentage of the 2020 imaging case volumes relative to 2019 across weeks 1 to 16 stratiﬁed by
patient service locations. The vertical red line at week 10 indicates when the ﬁrst patient in New York City tested positive for
coronavirus disease 2019. Calendar weeks are presented on the x axis and the imaging volume percentage on the y axis. At
week 16, the 2020 imaging case volumes represented 54.44%, 95.85%, and 12.45% of the imaging volume in 2019 for the
emergency department (ED), inpatient, and outpatient settings, respectively.
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Table 3. Comparison of years 2020 and 2019 mean weekly imaging volumes and 95% CIs for the post-COVID-19 (weeks
10-16) period according to imaging modality types stratiﬁed by patient service locations
2020 Year

2019 Year

Mean

95% CI

Mean

95% CI

P value

Emergency department
CT
Interventional
MRI
Nuclear medicine
Ultrasound
X-ray
Total

3,866.9
8.7
70.0
11.9
834.0
7,005.9
11,797.3

2,668.3-5,065.4
5.1-12.3
34.8-105.2
2.0-21.7
425.2-1,242.8
6,097.5-7,914.3
9,498.2-14,096.3

5,961.1
11.9
165.9
24.9
1,772.6
8,146.4
16,082.7

5,823.7-6,098.6
7.1-16.6
149.7-182.0
20.2-29.6
1,743.8-1,801.4
7,980.0-8,312.9
15,867.8-16,297.7

.005*
.219
<.001*
.018*
.001*
.022*
.004*

Inpatient
CT
Interventional
MRI
Nuclear medicine
Ultrasound
X-ray
Total

1,502.1
307.7
402.4
75.7
1,002.6
6,447.7
9,738.3

1,139.2-1,865.1
211.3-404.1
186.5-618.3
29.2-122.3
692.5-1,312.6
5,459.5-7,436.0
87,49.2-10,727.4

2,070.7
503.0
792.7
191.9
1,490.0
6,223.4
11,271.7

1,992.1-2,149.3
486.5-519.5
753.5-831.9
173.1-210.6
1,439.3-1,540.7
5,988.4-6,458.5
10,952.6-11,590.9

.008*
.002*
.004*
<.001*
.008*
.599
.008*

Outpatient
CT
Interventional
Mammography
MRI
Nuclear medicine
Ultrasound
X-ray
Total

321.0
162.4
382.1
318.6
154.9
581.4
926.7
2,847.1

66.8-575.2
86.8-238.0
4.5-759.8
79.6-557.6
39.4-270.3
107.4-1,055.5
107.6-1,745.9
504.3-5,190.0

712.4
280.7
919.0
660.6
303.0
1,288.9
2,393.6
6,558.1

692.9-732.0
260.9-300.5
829.6-1,008.4
644.6-676.6
284.9-321.1
1,240.1-1,337.6
2,321.6-2,465.5
6,403.9-6,712.4

.009*
.008*
.013*
.013*
.020*
.011*
.005*
.008*

3,909.6-7,470.4
307.7-650.0
1,242.3-3,593.7
306.9-1,275.1
72.7-412.2
13,193.6-15,567.0
19,477.7-29,287.7

8,744.3
795.6
4,551.4
1,619.1
519.7
16,763.4
33,912.6

8,557.2-8,931.4
783.3-807.9
4,477.5-4,625.4
1,569.2-1,669.1
498.4-541.1
16,431.2-17,095.7
33,429.3-34,395.9

.006*
.004*
.004*
.006*
.007*
.002*
.003*

Imaging Volumes

All patient service locations
CT
5,690.0
Interventional
478.9
Ultrasound
2,418.0
MRI
791.0
Nuclear medicine
242.4
X-ray
14,380.3
Total
24,382.7

CI ¼ conﬁdence interval; COVID-19 ¼ coronavirus disease 2019.
*P  .05.

particular, radiology groups that are mainly comprised of
outpatient imaging will be most severely affected
according to anecdotal evidence [6] and the real-world
data presented in this study.
The main limitation of this study is the retrospective
design using aggregate data, thus limiting more detailed
analyses evaluating the potential decline of imaging case
volumes by CPT codes (ie, brain MRI, chest CT, abdominal
x-ray) or clinical indications (International Classiﬁcation of
Diseases, 10th rev codes). It is possible that imaging case
volumes for some CPT codes or clinical indications changed
more than others. Another limitation is that our health care
Journal of the American College of Radiology
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institution is located in the epicenter of the COVID-19
pandemic, potentially limiting the generalizability of these
results. With nationwide spread of COVID-19, it is likely
that almost every region will directly or indirectly
experience the impact of this pandemic. Even though
these results may serve as a worst-case scenario, speciﬁc
analyses of imaging case volumes in less severely affected
regions would be warranted for comprehensive evaluation.
In summary, as radiology practices prepare to minimize
the impact of the COVID-19 pandemic on imaging case
volumes and begin to formulate transition plans in the recovery period, the results from this study provide real-world
871

data to inform radiology practices toward evidence-based
decisions. Because the duration of the COVID-19
pandemic remains uncertain, this study may assist in guiding short-term and long-term practice decisions based on the
magnitude of imaging volume decline across different patient service locations and speciﬁc imaging modality types
during the COVID-19 pandemic. Importantly, these data
may play a vital role in demonstrating the impact on radiology practices to support requests for funding relief from
the government COVID-19 recovery plans.

TAKE-HOME POINTS
-

This study reveals an overall 28% decline in the total
imaging volume during the COVID-19 pandemic (7
weeks) including all patient service locations and imaging modality types.

-

Imaging volume deterioration varied by location, with
the greatest decline observed by week 16 in the
outpatient setting (88%) followed by the emergency
department (46%) and inpatient (4%) settings.

-

Imaging volume deterioration also varied by modality
type, with the greatest decline observed by week 16 in
mammography (94%), followed in descending order
by nuclear medicine (85%), MRI (74%), ultrasound
(64%), interventional radiology (56%), CT (46%),
and x-ray (22%).

-

As radiology practices prepare to minimize the impact
of the COVID-19 pandemic on imaging case volumes
and begin to formulate transition plans in the recovery
period, the results from this study provide real-world
data to inform radiology practices toward evidencebased decisions.
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